A long-acting GLP-1 receptor agonist
The headline is that Semaglutide binds the GLP-1 receptor and resists breakdown long enough to study over days. Research looks at glucose- and meal-signaling pathways in cell, animal, and clinical models. None of it is a claim about what it does for a person.

